Browse By Cancer Type Result Page of OvirusTdb

The total number of records retrieved from this search are 100. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_2132AdenovirusMutantDNAAdenoviridaeDeletion of E1BK55KD gene and addition of TRAIL geneYesNoVirus expressing TRAIL geneATCCHuman hepatocellular carcinoma cell lineHuh-7NANACrystal violet staining10 MOISome cell death observedNoNoNA No responseNAInduction of apoptosis in cancer as measured by TUNEL assayNANA21979578
OV_2133AdenovirusMutantDNAAdenoviridaeDeletion of E1BK55KD gene and addition of TRAIL geneYesNoVirus expressing TRAIL geneATCCHuman hepatocellular carcinoma cell lineHuh-7NANACrystal violet staining100 MOIMost of the cells are diedNoNoNA No responseNAInduction of apoptosis in cancer as measured by TUNEL assayNANA21979578
OV_2134AdenovirusMutantDNAAdenoviridaeDeletion of E1BK55KD gene and addition of TRAIL geneYesNoVirus expressing TRAIL geneATCCHuman hepatocellular carcinoma cell lineHepG2NANACrystal violet staining0.1 MOISome cell death observedNoNoNA No responseNAInduction of apoptosis in cancer as measured by TUNEL assayNANA21979578
OV_2135AdenovirusMutantDNAAdenoviridaeDeletion of E1BK55KD gene and addition of TRAIL geneYesNoVirus expressing TRAIL geneATCCHuman hepatocellular carcinoma cell lineHepG2NANACrystal violet staining1 MOISome cell death observedNoNoNA No responseNAInduction of apoptosis in cancer as measured by TUNEL assayNANA21979578
OV_2136AdenovirusMutantDNAAdenoviridaeDeletion of E1BK55KD gene and addition of TRAIL geneYesNoVirus expressing TRAIL geneATCCHuman hepatocellular carcinoma cell lineHepG2NANACrystal violet staining10 MOISome cell death observedNoNoNA No responseNAInduction of apoptosis in cancer as measured by TUNEL assayNANA21979578
OV_2137AdenovirusMutantDNAAdenoviridaeDeletion of E1BK55KD gene and addition of TRAIL geneYesNoVirus expressing TRAIL geneATCCHuman hepatocellular carcinoma cell lineHepG2NANACrystal violet staining100 MOIMost of the cells are diedNoNoNA No responseNAInduction of apoptosis in cancer as measured by TUNEL assayNANA21979578
OV_2138AdenovirusMutantDNAAdenoviridaeDeletion of E1BK55KD gene and addition of TRAIL geneYesNoVirus expressing TRAIL geneATCCHuman hepatocellular carcinoma cell lineHuh-7NANANANANABALB/c mice xenograft for Huh7 cell line (5.0E+6 × 10⁶ pfu)2.0E+9 pfuNA Significant reduction in tumor volume below 100mm and increase in median survival time after 57 daysIntratumoralInduction of apoptosis in cancer as measured by TUNEL assayNANA21979578
OV_2528AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell lineHuh-7NANAMTT assay0.1 MOI90% cells are viableNoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2529AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell lineHuh-7NANAMTT assay1 MOI100% cells are viableNoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2530AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell lineHuh-7NANAMTT assay10 MOI35% cells are viableNoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2531AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell lineHep3BNANAMTT assay0.1 MOI100% cells are viableNoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2532AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell lineHep3BNANAMTT assay1 MOI90% cells are viableNoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2533AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell lineHep3BNANAMTT assay10 MOI60% cellsa are viableNoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2534AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay0.1 MOI100% cells are viableNoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2535AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay1 MOI90% cells are viableNoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2536AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay10 MOI30% cells are viableNoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2537AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell lineHepG2NANAMTT assay10 MOI90% cells viable after day 1NoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2538AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell lineHepG2NANAMTT assay10 MOI80% cells viable after day 2NoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2539AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell lineHepG2NANAMTT assay10 MOI70% cells viable after day 3NoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2540AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell lineHepG2NANAMTT assay10 MOI60% cells viable after day 4NoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2541AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell lineHep3BNANAMTT assay10 MOI90% cells viable after day 1NoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2542AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell lineHep3BNANAMTT assay10 MOI80% cells viable after day 2NoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2543AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell lineHep3BNANAMTT assay10 MOI70% cells viable after day 3NoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2544AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell lineHep3BNANAMTT assay10 MOI60% cells viable after day 4NoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2545AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay10 MOI100% cells viable after day 1NoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2546AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay10 MOI80% cells viable after day 2NoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2547AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay10 MOI40% cells viable after day 3NoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2548AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay10 MOI10% cells viable after day 4NoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2549AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell lineHuh-7NANAMTT assay10 MOI90% cells viable after day 1NoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2550AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell lineHuh-7NANAMTT assay10 MOI70% cells viable after day 2NoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2551AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell lineHuh-7NANAMTT assay10 MOI50% cells viable after day 3NoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2552AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell lineHuh-7NANAMTT assay10 MOI30% cells viable after day 4NoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2553AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell lineHuh-7NANANANANABALB/c nude mice xenograft for Huh7 cell line (1.0E+7)3.0E+8 pfuNA Reduction in tumor volume below 425mm after 16 daysIntratumoralInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2554AdenovirusSG600-IL-24DNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineHepG21000 cellsNAMTT assay10 MOI90.2% cell survival after 24 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2555AdenovirusSG600-IL-24DNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineHepG21000 cellsNAMTT assay10 MOI70.3% cell survival after 48 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2556AdenovirusSG600-IL-24DNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineHepG21000 cellsNAMTT assay10 MOI56.2% cell survival after 72 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2557AdenovirusSG600-IL-24DNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineHepG21000 cellsNAMTT assay10 MOI25.3% cell survival after 96 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2558AdenovirusSG600-IL-24+IFNDNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 gene and addition of INYesNoVirus expressing IL-24 gene and IFN geneATCCHuman hepatocellular carcinoma cell lineHepG21000 cellsNAMTT assay10 MOI88.3% cell survival after 24 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2559AdenovirusSG600-IL-24+IFNDNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 gene and addition of INYesNoVirus expressing IL-24 gene and IFN geneATCCHuman hepatocellular carcinoma cell lineHepG21000 cellsNAMTT assay10 MOI64% cell survival after 48 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2560AdenovirusSG600-IL-24+IFNDNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 gene and addition of INYesNoVirus expressing IL-24 gene and IFN geneATCCHuman hepatocellular carcinoma cell lineHepG21000 cellsNAMTT assay10 MOI35.2% cell survival after 72 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2561AdenovirusSG600-IL-24+IFNDNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 gene and addition of INYesNoVirus expressing IL-24 gene and IFN geneATCCHuman hepatocellular carcinoma cell lineHepG21000 cellsNAMTT assay10 MOI17.7% cell survival after 96 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2562AdenovirusSG600-IL-24DNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineMHCC97L1000 cellsNAMTT assay10 MOI88.2% cell survival after 24 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2563AdenovirusSG600-IL-24DNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineMHCC97L1000 cellsNAMTT assay10 MOI72.3% cell survival after 48 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2564AdenovirusSG600-IL-24DNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineMHCC97L1000 cellsNAMTT assay10 MOI58% cell survival after 72 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2565AdenovirusSG600-IL-24DNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineMHCC97L1000 cellsNAMTT assay10 MOI28% cell survival after 96 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2566AdenovirusSG600-IL-24+IFNDNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 gene and addition of INYesNoVirus expressing IL-24 gene and IFN geneATCCHuman hepatocellular carcinoma cell lineMHCC97L1000 cellsNAMTT assay10 MOI84.3% cell survival after 24 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2567AdenovirusSG600-IL-24+IFNDNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 gene and addition of INYesNoVirus expressing IL-24 gene and IFN geneATCCHuman hepatocellular carcinoma cell lineMHCC97L1000 cellsNAMTT assay10 MOI66.2% cell survival after 48 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2568AdenovirusSG600-IL-24+IFNDNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 gene and addition of INYesNoVirus expressing IL-24 gene and IFN geneATCCHuman hepatocellular carcinoma cell lineMHCC97L1000 cellsNAMTT assay10 MOI54.5% cell survival after 72 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2569AdenovirusSG600-IL-24+IFNDNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 gene and addition of INYesNoVirus expressing IL-24 gene and IFN geneATCCHuman hepatocellular carcinoma cell lineMHCC97L1000 cellsNAMTT assay10 MOI24% cell survival after 96 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2570AdenovirusSG600-IL-24DNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineHCCLM31000 cellsNAMTT assay10 MOI90% cell survival after 24 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2571AdenovirusSG600-IL-24DNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineHCCLM31000 cellsNAMTT assay10 MOI72.5% cell survival after 48 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2572AdenovirusSG600-IL-24DNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineHCCLM31000 cellsNAMTT assay10 MOI50.2% cell survival after 72 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2573AdenovirusSG600-IL-24DNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineHCCLM31000 cellsNAMTT assay10 MOI28.2% cell survival after 96 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2574AdenovirusSG600-IL-24+IFNDNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 gene and addition of INYesNoVirus expressing IL-24 gene and IFN geneATCCHuman hepatocellular carcinoma cell lineHCCLM31000 cellsNAMTT assay10 MOI87.2% cell survival after 24 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2575AdenovirusSG600-IL-24+IFNDNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 gene and addition of INYesNoVirus expressing IL-24 gene and IFN geneATCCHuman hepatocellular carcinoma cell lineHCCLM31000 cellsNAMTT assay10 MOI68% cell survival after 48 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2576AdenovirusSG600-IL-24+IFNDNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 gene and addition of INYesNoVirus expressing IL-24 gene and IFN geneATCCHuman hepatocellular carcinoma cell lineHCCLM31000 cellsNAMTT assay10 MOI45% cell survival after 72 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2577AdenovirusSG600-IL-24+IFNDNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 gene and addition of INYesNoVirus expressing IL-24 gene and IFN geneATCCHuman hepatocellular carcinoma cell lineHCCLM31000 cellsNAMTT assay10 MOI25% cell survival after 96 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2578AdenovirusSG600-IL-24+IFNDNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 gene and addition of INYesNoVirus expressing IL-24 gene and IFN geneATCCHuman hepatocellular carcinoma cell lineHCCLM3NANANANANABALB/c nude mice xenograft for HCCLM3 cell line2.0E+8 pfuNA Significant reduction in tumor volume from the onset of tretament and till the end of 42 days and increase in median survival timeIntratumoralCombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2665Measles virusMV-EdmRNAParamyxoviridaeInsertion of human CEA gene upstream of MV N geneYesNoNoATCCHuman hepatoblastoma cell lineHepG22.0E+5 cells per wellNACell proliferation assay kit0.01 MOI100% cell survival after 24 hoursNoNoNA No responseNAInduction of apoptosis in cancerIncrease expression of CD46NA23009685
OV_2666Measles virusMV-EdmRNAParamyxoviridaeInsertion of human CEA gene upstream of MV N geneYesNoNoATCCHuman hepatoblastoma cell lineHepG22.0E+5 cells per wellNACell proliferation assay kit0.01 MOI100% cell survival after 48 hoursNoNoNA No responseNAInduction of apoptosis in cancerIncrease expression of CD46NA23009685
OV_2667Measles virusMV-EdmRNAParamyxoviridaeInsertion of human CEA gene upstream of MV N geneYesNoNoATCCHuman hepatoblastoma cell lineHepG22.0E+5 cells per wellNACell proliferation assay kit0.01 MOI100% cell survival after 72 hoursNoNoNA No responseNAInduction of apoptosis in cancerIncrease expression of CD46NA23009685
OV_2668Measles virusMV-EdmRNAParamyxoviridaeInsertion of human CEA gene upstream of MV N geneYesNoNoATCCHuman hepatoblastoma cell lineHepG22.0E+5 cells per wellNACell proliferation assay kit0.01 MOI100% cell survival after 96 hoursNoNoNA No responseNAInduction of apoptosis in cancerIncrease expression of CD46NA23009685
OV_2669Measles virusMV-EdmRNAParamyxoviridaeInsertion of human CEA gene upstream of MV N geneYesNoNoATCCHuman hepatoblastoma cell lineHepG22.0E+5 cells per wellNACell proliferation assay kit0.1 MOI100% cell survival after 24 hoursNoNoNA No responseNAInduction of apoptosis in cancerIncrease expression of CD46NA23009685
OV_2670Measles virusMV-EdmRNAParamyxoviridaeInsertion of human CEA gene upstream of MV N geneYesNoNoATCCHuman hepatoblastoma cell lineHepG22.0E+5 cells per wellNACell proliferation assay kit0.1 MOI90% cell survival after 48 hoursNoNoNA No responseNAInduction of apoptosis in cancerIncrease expression of CD46NA23009685
OV_2671Measles virusMV-EdmRNAParamyxoviridaeInsertion of human CEA gene upstream of MV N geneYesNoNoATCCHuman hepatoblastoma cell lineHepG22.0E+5 cells per wellNACell proliferation assay kit0.1 MOI80% cell survival after 72 hoursNoNoNA No responseNAInduction of apoptosis in cancerIncrease expression of CD46NA23009685
OV_2672Measles virusMV-EdmRNAParamyxoviridaeInsertion of human CEA gene upstream of MV N geneYesNoNoATCCHuman hepatoblastoma cell lineHepG22.0E+5 cells per wellNACell proliferation assay kit0.1 MOI60% cell survival after 96 hoursNoNoNA No responseNAInduction of apoptosis in cancerIncrease expression of CD46NA23009685
OV_2673Measles virusMV-EdmRNAParamyxoviridaeInsertion of human CEA gene upstream of MV N geneYesNoNoATCCHuman hepatoblastoma cell lineHepG22.0E+5 cells per wellNACell proliferation assay kit1 MOI90% cell survival after 24 hoursNoNoNA No responseNAInduction of apoptosis in cancerIncrease expression of CD46NA23009685
OV_2674Measles virusMV-EdmRNAParamyxoviridaeInsertion of human CEA gene upstream of MV N geneYesNoNoATCCHuman hepatoblastoma cell lineHepG22.0E+5 cells per wellNACell proliferation assay kit1 MOI80% cell survival after 48 hoursNoNoNA No responseNAInduction of apoptosis in cancerIncrease expression of CD46NA23009685
OV_2675Measles virusMV-EdmRNAParamyxoviridaeInsertion of human CEA gene upstream of MV N geneYesNoNoATCCHuman hepatoblastoma cell lineHepG22.0E+5 cells per wellNACell proliferation assay kit1 MOI70% cell survival after 72 hoursNoNoNA No responseNAInduction of apoptosis in cancerIncrease expression of CD46NA23009685
OV_2676Measles virusMV-EdmRNAParamyxoviridaeInsertion of human CEA gene upstream of MV N geneYesNoNoATCCHuman hepatoblastoma cell lineHepG22.0E+5 cells per wellNACell proliferation assay kit1 MOI50% cell survival after 96 hoursNoNoNA No responseNAInduction of apoptosis in cancerIncrease expression of CD46NA23009685
OV_2677Measles virusMV-EdmRNAParamyxoviridaeInsertion of human CEA gene upstream of MV N geneYesNoNoATCCHuman hepatoblastoma cell lineHuh-62.0E+5 cells per wellNACell proliferation assay kit0.01 MOI100% cell survival after 24 hoursNoNoNA No responseNAInduction of apoptosis in cancerIncrease expression of CD46NA23009685
OV_2678Measles virusMV-EdmRNAParamyxoviridaeInsertion of human CEA gene upstream of MV N geneYesNoNoATCCHuman hepatoblastoma cell lineHuh-62.0E+5 cells per wellNACell proliferation assay kit0.01 MOI100% cell survival after 48 hoursNoNoNA No responseNAInduction of apoptosis in cancerIncrease expression of CD46NA23009685
OV_2679Measles virusMV-EdmRNAParamyxoviridaeInsertion of human CEA gene upstream of MV N geneYesNoNoATCCHuman hepatoblastoma cell lineHuh-62.0E+5 cells per wellNACell proliferation assay kit0.01 MOI90% cell survival after 72 hoursNoNoNA No responseNAInduction of apoptosis in cancerIncrease expression of CD46NA23009685
OV_2680Measles virusMV-EdmRNAParamyxoviridaeInsertion of human CEA gene upstream of MV N geneYesNoNoATCCHuman hepatoblastoma cell lineHuh-62.0E+5 cells per wellNACell proliferation assay kit0.01 MOI80% cell survival after 96 hoursNoNoNA No responseNAInduction of apoptosis in cancerIncrease expression of CD46NA23009685
OV_2681Measles virusMV-EdmRNAParamyxoviridaeInsertion of human CEA gene upstream of MV N geneYesNoNoATCCHuman hepatoblastoma cell lineHuh-62.0E+5 cells per wellNACell proliferation assay kit0.1 MOI100% cell survival after 24 hoursNoNoNA No responseNAInduction of apoptosis in cancerIncrease expression of CD46NA23009685
OV_2682Measles virusMV-EdmRNAParamyxoviridaeInsertion of human CEA gene upstream of MV N geneYesNoNoATCCHuman hepatoblastoma cell lineHuh-62.0E+5 cells per wellNACell proliferation assay kit0.1 MOI90% cell survival after 48 hoursNoNoNA No responseNAInduction of apoptosis in cancerIncrease expression of CD46NA23009685
OV_2683Measles virusMV-EdmRNAParamyxoviridaeInsertion of human CEA gene upstream of MV N geneYesNoNoATCCHuman hepatoblastoma cell lineHuh-62.0E+5 cells per wellNACell proliferation assay kit0.1 MOI90% cell survival after 72 hoursNoNoNA No responseNAInduction of apoptosis in cancerIncrease expression of CD46NA23009685
OV_2684Measles virusMV-EdmRNAParamyxoviridaeInsertion of human CEA gene upstream of MV N geneYesNoNoATCCHuman hepatoblastoma cell lineHuh-62.0E+5 cells per wellNACell proliferation assay kit0.1 MOI70% cell survival after 96 hoursNoNoNA No responseNAInduction of apoptosis in cancerIncrease expression of CD46NA23009685
OV_2685Measles virusMV-EdmRNAParamyxoviridaeInsertion of human CEA gene upstream of MV N geneYesNoNoATCCHuman hepatoblastoma cell lineHuh-62.0E+5 cells per wellNACell proliferation assay kit1 MOI100% cell survival after 24 hoursNoNoNA No responseNAInduction of apoptosis in cancerIncrease expression of CD46NA23009685
OV_2686Measles virusMV-EdmRNAParamyxoviridaeInsertion of human CEA gene upstream of MV N geneYesNoNoATCCHuman hepatoblastoma cell lineHuh-62.0E+5 cells per wellNACell proliferation assay kit1 MOI80% cell survival after 48 hoursNoNoNA No responseNAInduction of apoptosis in cancerIncrease expression of CD46NA23009685
OV_2687Measles virusMV-EdmRNAParamyxoviridaeInsertion of human CEA gene upstream of MV N geneYesNoNoATCCHuman hepatoblastoma cell lineHuh-62.0E+5 cells per wellNACell proliferation assay kit1 MOI70% cell survival after 72 hoursNoNoNA No responseNAInduction of apoptosis in cancerIncrease expression of CD46NA23009685
OV_2688Measles virusMV-EdmRNAParamyxoviridaeInsertion of human CEA gene upstream of MV N geneYesNoNoATCCHuman hepatoblastoma cell lineHuh-62.0E+5 cells per wellNACell proliferation assay kit1 MOI50% cell survival after 96 hoursNoNoNA No responseNAInduction of apoptosis in cancerIncrease expression of CD46NA23009685
OV_2689Measles virusMV-EdmRNAParamyxoviridaeInsertion of human CEA gene upstream of MV N geneYesNoNoATCCHuman hepatoblastoma cell lineHepG2NANANANANANude mice xenograft for Hep2G (5.0E+6 cell)1.0E+7 TCID50NA Reduction in tumor volume to 300mm after 37 days as compared to control 550mm and increase in survival time above 120 days as compared to control 30 daysIntratumoralInduction of apoptosis in cancerIncrease expression of CD46NA23009685
OV_2690AdenovirusAdCN205-IL12DNAAdenoviridaeNoneYesNoVirus expressing IL-12 geneShanghai cell collectionHuman hepatocellular carcinoma cell lineBEL-74041.0E+4 cells per wellNASpectrophotometer10 MOI85% cell viability after 24 hoursNoNoNA No responseNANANANA23028626
OV_2691AdenovirusAdCN205-IL12DNAAdenoviridaeNoneYesNoVirus expressing IL-12 geneShanghai cell collectionHuman hepatocellular carcinoma cell lineBEL-74041.0E+4 cells per wellNASpectrophotometer10 MOI80% cell viability after 48 hoursNoNoNA No responseNANANANA23028626
OV_2692AdenovirusAdCN205-IL12DNAAdenoviridaeNoneYesNoVirus expressing IL-12 geneShanghai cell collectionHuman hepatocellular carcinoma cell lineBEL-74041.0E+4 cells per wellNASpectrophotometer10 MOI60% cell viability after 72 hoursNoNoNA No responseNANANANA23028626
OV_2693AdenovirusAdCN205-IL12DNAAdenoviridaeNoneYesNoVirus expressing IL-12 geneShanghai cell collectionHuman hepatocellular carcinoma cell lineBEL-74041.0E+4 cells per wellNASpectrophotometer10 MOI50% cell viability after 96 hoursNoNoNA No responseNANANANA23028626
OV_2694AdenovirusAdCN205-IL12DNAAdenoviridaeNoneYesNoVirus expressing IL-12 geneATCCHuman hepatocellular carcinoma cell lineHep3B1.0E+4 cells per wellNASpectrophotometer10 MOI80% cell viability after 24 hoursNoNoNA No responseNANANANA23028626
OV_2695AdenovirusAdCN205-IL12DNAAdenoviridaeNoneYesNoVirus expressing IL-12 geneATCCHuman hepatocellular carcinoma cell lineHep3B1.0E+4 cells per wellNASpectrophotometer10 MOI60% cell viability after 48 hoursNoNoNA No responseNANANANA23028626
OV_2696AdenovirusAdCN205-IL12DNAAdenoviridaeNoneYesNoVirus expressing IL-12 geneATCCHuman hepatocellular carcinoma cell lineHep3B1.0E+4 cells per wellNASpectrophotometer10 MOI40% cell viability after 72 hoursNoNoNA No responseNANANANA23028626
OV_2697AdenovirusAdCN205-IL12DNAAdenoviridaeNoneYesNoVirus expressing IL-12 geneATCCHuman hepatocellular carcinoma cell lineHep3B1.0E+4 cells per wellNASpectrophotometer10 MOI40% cell viability after 96 hoursNoNoNA No responseNANANANA23028626
OV_2698AdenovirusAdCN205-IL12DNAAdenoviridaeNoneYesNoVirus expressing IL-12 geneShanghai cell collectionHuman hepatocellular carcinoma cell lineHuh-71.0E+4 cells per wellNASpectrophotometer10 MOI85% cell viability after 24 hoursNoNoNA No responseNANANANA23028626
OV_2699AdenovirusAdCN205-IL12DNAAdenoviridaeNoneYesNoVirus expressing IL-12 geneShanghai cell collectionHuman hepatocellular carcinoma cell lineHuh-71.0E+4 cells per wellNASpectrophotometer10 MOI80% cell viability after 48 hoursNoNoNA No responseNANANANA23028626
OV_2700AdenovirusAdCN205-IL12DNAAdenoviridaeNoneYesNoVirus expressing IL-12 geneShanghai cell collectionHuman hepatocellular carcinoma cell lineHuh-71.0E+4 cells per wellNASpectrophotometer10 MOI70% cell viability after 72 hoursNoNoNA No responseNANANANA23028626
OV_2701AdenovirusAdCN205-IL12DNAAdenoviridaeNoneYesNoVirus expressing IL-12 geneShanghai cell collectionHuman hepatocellular carcinoma cell lineHuh-71.0E+4 cells per wellNASpectrophotometer10 MOI40% cell viability after 96 hoursNoNoNA No responseNANANANA23028626
OV_2702AdenovirusAdCN205-IL12DNAAdenoviridaeNoneNoVirus in combination with CIKVirus expressing IL-12 geneShanghai cell collectionHuman hepatocellular carcinoma cell lineHuh-71.0E+4 cells per wellNASpectrophotometer10 MOI70% cell viability after 24 hoursNoNoNA No responseNANANANA23028626
OV_2703AdenovirusAdCN205-IL12DNAAdenoviridaeNoneNoVirus in combination with CIKVirus expressing IL-12 geneShanghai cell collectionHuman hepatocellular carcinoma cell lineHuh-71.0E+4 cells per wellNASpectrophotometer10 MOI40% cell viability after 48 hoursNoNoNA No responseNANANANA23028626
OV_2704AdenovirusAdCN205-IL12DNAAdenoviridaeNoneNoVirus in combination with CIKVirus expressing IL-12 geneShanghai cell collectionHuman hepatocellular carcinoma cell lineHuh-71.0E+4 cells per wellNASpectrophotometer10 MOI20% cell viability after 72 hoursNoNoNA No responseNANANANA23028626
OV_2705AdenovirusAdCN205-IL12DNAAdenoviridaeNoneNoVirus in combination with CIKVirus expressing IL-12 geneATCCHuman hepatocellular carcinoma cell lineHep3B1.0E+4 cells per wellNASpectrophotometer10 MOI90% cell viability after 24 hoursNoNoNA No responseNANANANA23028626
OV_2706AdenovirusAdCN205-IL12DNAAdenoviridaeNoneNoVirus in combination with CIKVirus expressing IL-12 geneATCCHuman hepatocellular carcinoma cell lineHep3B1.0E+4 cells per wellNASpectrophotometer10 MOI80% cell viability after 48 hoursNoNoNA No responseNANANANA23028626